A detailed history of Riverview Trust CO transactions in Natera, Inc. stock. As of the latest transaction made, Riverview Trust CO holds 4 shares of NTRA stock, worth $634. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Holding current value
$634
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$97.75 - $129.67 $391 - $518
4 New
4 $0
Q2 2022

Jul 27, 2022

SELL
$28.13 - $44.54 $6,413 - $10,155
-228 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$30.32 - $91.33 $6,912 - $20,823
228 New
228 $9,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.4B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.